Skip to content
RapidCenter UK

Zimbabwe Declines ‘Unbalanced’ American Health Aid Deal Because of Data Fears

Health funding image
The offered American financial assistance was aimed at initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has declined a significant American health deal valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's request for sensitive data.

This move came to light after a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa deemed the deal was "lopsided".

An official spokesman later explained that the United States was seeking genetic material for research and profit but was unwilling to share the resulting advantages from any future vaccines.

"We must now begin the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has called for continued dialogue to find a agreement suitable to all parties so the nation's vital HIV programme can be sustained.

Broader Background

Zimbabwe's decision follows a comparable situation in Kenya, where a court blocked a similar deal with the US after legal challenges were filed about the safety of citizens' medical information.

After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had overseen aid for the US government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.

Based on statements, 16 nations in Africa have so far agreed to these new health pacts, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration might have yielded significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment through US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".

"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.

"Put simply, our nation would supply the raw materials for medical research without any assurance that the final treatments would be available to our people if a future health crisis emerge."

Sovereignty and International Frameworks

Mangwana further noted that the American exit from the global health body and its push of one-on-one health agreements were upending structures previously set up via the international organization.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.

"This mechanism is intended to guarantee that when a country contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.

"We welcome further dialogue with our American counterparts on how future co-operation could be designed in a way that respects the independence and dignity of each country."

Medical Community Response

A leading public health body stated it acknowledged the official position, but suggested that negotiations need to persist considering much of the nation's Aids initiatives relied on foreign aid.

"In cases where technical issues arise, including those relating to information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group added.

This impasse underscores the continuing challenges between accepting crucial foreign assistance and protecting national sovereignty in an increasingly interconnected world.

JL
The writer

Joanne Lopez

Tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on business and society.

RapidCenter UK

Type to search articles.